Could a simple exercise breathing test replace invasive heart probes?
NCT ID NCT04450459
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial tests whether a non-invasive exercise test that measures oxygen uptake (ergospirometry) can accurately detect heart ischemia in people with stable angina. Currently, the most reliable method is an invasive procedure called FFR, which measures blood flow during cardiac catheterization. The study compares the diagnostic accuracy of the ergospirometer test against FFR to see if it could serve as a better non-invasive alternative.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ergospirometer test (a non-invasive exercise test that measures oxygen uptake and breathing during physical activity)
- What this could lead to
- If successful, this could provide a more accurate, non-invasive way to detect heart ischemia, potentially reducing the need for invasive procedures.
- What could go wrong
- The trial is relatively small and early-stage. The new test may not prove accurate enough to replace current methods, and individual results can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
121 people
The number who actually took part.
- Started
-
Jan 2019
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with suspected CAD presenting for diagnostic testing/ coronary angiography
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * stable Angina (CCS \>1-3) with suspected CAD or * dyspnoea at exertion NYHA \>2 or * signs of ischemia within SPECT or exercise electrocardiography * willingness to participate in the trial Exclusion Criteria: * Unstable angina or myocardial infarction within the last 2 weeks * inability to perform bicycle exercise test * significant valvular disease * HOCM * av- block \>I degree * asthma bronchiales
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stable angina are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universityhospital
Jena, 07747, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI software may replace invasive heart tests — a validation study puts it to the test
- AI and poop samples: the future of heart attack prevention?
- Gum cleaning may help your heart, new study suggests
- Heart study: is early catheterization better than drugs for chest pain?
- Heart procedure put to the test: placebo surgery reveals true benefits for chest pain
- Heart artery study tests smarter imaging to prevent attacks